Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fucus vesiculosus is a type of brown seaweed commonly known as bladderwrack. It grows in the Baltic Sea, Atlantic Ocean, and North Pacific Ocean. The whole plant is used medicinally and as a dietary supplement. Fucus vesiculosus contains varying amounts of iodine and fucoidan (a sulfated polysaccharide), which are thought to contribute to its biological effects. Iodine from Fucus vesiculosus may help prevent or treat some thyroid disorders by supporting thyroid hormone synthesis; it also has been suggested to have antidiabetic effects and influence hormone levels[1][2][4]. Fucoidan extracted from this seaweed has demonstrated potential benefits for immune health and gut/digestive health[6]. However, there is insufficient scientific evidence supporting its effectiveness for these uses[1][2]. It is primarily marketed as a dietary supplement ingredient rather than an approved pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fucus vesiculosus.